Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mardepodect in Early Huntington's Disease
NCT01806896Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mardepodect in Huntington's disease (HD), sponsored by Pfizer. Started Sep 2013; status: completed.
02
Drugs
mardepodect
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT01806896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01806896.